메뉴 건너뛰기




Volumn 34, Issue 8, 2004, Pages 755-770

Disposition of CP-671, 305, a selective phosphodiesterase 4 inhibitor in preclinical species

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [[[2 (BENZO[1,3]DIOXOL 5 YLOXY)PYRIDINE 3 CARBONYL]AMINO]METHYL] 3 FLUOROPHENOXY]PROPIONIC ACID; BUFURALOL; CP 671305; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DICLOFENAC; ERYTHROMYCIN; FURAFYLLINE; KETOCONAZOLE; MEPHENYTOIN; MIDAZOLAM; PHENACETIN; PHOSPHODIESTERASE IV INHIBITOR; PLASMA PROTEIN; QUINIDINE; SULFAPHENAZOLE; TESTOSTERONE; TICLOPIDINE; UNCLASSIFIED DRUG;

EID: 8444227836     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/00498250400005682     Document Type: Article
Times cited : (21)

References (39)
  • 1
    • 0028802726 scopus 로고
    • Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
    • BEAVO, J. A., 1995, Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiological Reviews, 75, 725-748.
    • (1995) Physiological Reviews , vol.75 , pp. 725-748
    • Beavo, J.A.1
  • 2
    • 0018606615 scopus 로고
    • Noncompartmental determination of the steady-state volume of distribution
    • BENET, L. Z. and GALEAZZI, R. L., 1971, Noncompartmental determination of the steady-state volume of distribution. Journal of Pharmaceutical Sciences, 68, 1071-1074.
    • (1971) Journal of Pharmaceutical Sciences , vol.68 , pp. 1071-1074
    • Benet, L.Z.1    Galeazzi, R.L.2
  • 4
  • 5
    • 0032793959 scopus 로고    scopus 로고
    • OATP and p-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
    • CVETKOVIC, M., LEAKE, B., FROMM, M. F., WILKINSON, G. R. and KIM, R. B., 1999, OATP and p-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metabolism and Disposition, 27, 866-871.
    • (1999) Drug Metabolism and Disposition , vol.27 , pp. 866-871
    • Cvetkovic, M.1    Leake, B.2    Fromm, M.F.3    Wilkinson, G.R.4    Kim, R.B.5
  • 6
    • 0027275566 scopus 로고
    • Physiological parameters in laboratory animals and humans
    • DAVIES, B. and MORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmaceutical Research, 10, 1093-1095.
    • (1993) Pharmaceutical Research , vol.10 , pp. 1093-1095
    • Davies, B.1    Morris, T.2
  • 7
    • 0033178884 scopus 로고    scopus 로고
    • Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents
    • DOHERTY, A. M., 1999, Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents. Current Opinion in Chemical Biology, 3, 466-473.
    • (1999) Current Opinion in Chemical Biology , vol.3 , pp. 466-473
    • Doherty, A.M.1
  • 9
    • 0032899660 scopus 로고    scopus 로고
    • Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation
    • ESSAYAN, D. M., 1999, Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochemical Pharmacology, 57, 965-973.
    • (1999) Biochemical Pharmacology , vol.57 , pp. 965-973
    • Essayan, D.M.1
  • 11
    • 0025991541 scopus 로고
    • Determination of the mechanism of demethylenation of (methylenedioxy) phenyl compounds by cytochrome P450 using deuterium isotope effects
    • FUKUTO, J. M., KUMAGAI, Y. and CHO, A. K., 1991, Determination of the mechanism of demethylenation of (methylenedioxy)phenyl compounds by cytochrome P450 using deuterium isotope effects. Journal of Medicinal Chemistry, 34, 2871-2876.
    • (1991) Journal of Medicinal Chemistry , vol.34 , pp. 2871-2876
    • Fukuto, J.M.1    Kumagai, Y.2    Cho, A.K.3
  • 13
    • 0034942625 scopus 로고    scopus 로고
    • Cilomilast: A second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease
    • GIEMBYCZ, M. A., 2001, Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease. Expert Opinion on Investigational Drugs, 10, 1361-1379.
    • (2001) Expert Opinion on Investigational Drugs , vol.10 , pp. 1361-1379
    • Giembycz, M.A.1
  • 15
    • 0032201011 scopus 로고    scopus 로고
    • Pharmacokinetic aspects of measurement of glomerular filtration rate in the dog: A review
    • HEIENE, R. and MOE, L., 1998, Pharmacokinetic aspects of measurement of glomerular filtration rate in the dog: a review. Journal of Veterinary Internal Medicine, 12, 401-414.
    • (1998) Journal of Veterinary Internal Medicine , vol.12 , pp. 401-414
    • Heiene, R.1    Moe, L.2
  • 16
    • 0025121255 scopus 로고
    • Metabolism of methylenedioxymethamphetamine: Formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct
    • HIRAMATSU, M., KUMAGAI, Y., UNGER, S. E. and CHO, A. K., 1990, Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. Journal of Pharmacology and Experimental Therapeutics, 254, 521-527.
    • (1990) Journal of Pharmacology and Experimental Therapeutics , vol.254 , pp. 521-527
    • Hiramatsu, M.1    Kumagai, Y.2    Unger, S.E.3    Cho, A.K.4
  • 17
    • 17644445622 scopus 로고    scopus 로고
    • Transporters and xenobiotic disposition
    • KIM, R. B., 2002, Transporters and xenobiotic disposition. Toxicology, 181-182, 291-297.
    • (2002) Toxicology , vol.181-182 , pp. 291-297
    • Kim, R.B.1
  • 18
    • 0028078626 scopus 로고
    • Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: Inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid
    • LOPEZ-GARCIA, M. P., DANSETTE, P. M. and MANSUY, D., 1994, Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid. Biochemistry, 33, 166-175.
    • (1994) Biochemistry , vol.33 , pp. 166-175
    • Lopez-Garcia, M.P.1    Dansette, P.M.2    Mansuy, D.3
  • 19
    • 0029828960 scopus 로고    scopus 로고
    • Interspecies scaling: Predicting clearance of drugs in humans: Three different approaches
    • MAHMOOD, I. and BALIAN, J. D., 1996, Interspecies scaling: predicting clearance of drugs in humans: three different approaches. Xenobiotica, 26, 887-895.
    • (1996) Xenobiotica , vol.26 , pp. 887-895
    • Mahmood, I.1    Balian, J.D.2
  • 22
    • 0000501191 scopus 로고    scopus 로고
    • PDE4 inhibitors - A review of the recent patent literature
    • MARTIN, T. J., 2001, PDE4 inhibitors - a review of the recent patent literature. Investigational drugs, 4, 312-338.
    • (2001) Investigational Drugs , vol.4 , pp. 312-338
    • Martin, T.J.1
  • 23
    • 0033831197 scopus 로고    scopus 로고
    • An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation
    • MAYHEW, B. S., JONES, D. R. and HALL, S. D., 2000, An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. Drug Metabolism and Disposition, 28, 1031-1037.
    • (2000) Drug Metabolism and Disposition , vol.28 , pp. 1031-1037
    • Mayhew, B.S.1    Jones, D.R.2    Hall, S.D.3
  • 24
    • 0001074646 scopus 로고    scopus 로고
    • Subtypes of the type 4 cAMP phosphodiesterases: Structure, regulation and selective inhibition
    • MULLER, T., ENGELS, P. and FOZARD, J. R., 1996, Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition. Trends in Pharmacological Sciences, 17, 294-298.
    • (1996) Trends in Pharmacological Sciences , vol.17 , pp. 294-298
    • Muller, T.1    Engels, P.2    Fozard, J.R.3
  • 25
    • 0034232506 scopus 로고    scopus 로고
    • Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation
    • MURRAY, M., 2000, Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation. Current Drug Metabolism, 1, 67-84.
    • (2000) Current Drug Metabolism , vol.1 , pp. 67-84
    • Murray, M.1
  • 26
    • 0033863331 scopus 로고    scopus 로고
    • PDE4 inhibitors: Sustained patenting activity as leading drugs near the market
    • NORMAN, P., 2000, PDE4 inhibitors: sustained patenting activity as leading drugs near the market. Expert Opinion on Therapeutic Patents, 10, 1415-1427.
    • (2000) Expert Opinion on Therapeutic Patents , vol.10 , pp. 1415-1427
    • Norman, P.1
  • 27
    • 0033917295 scopus 로고    scopus 로고
    • Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, a herbal preparation used in the treatment of depression
    • OBACH, R. S., 2000, Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, a herbal preparation used in the treatment of depression. Journal of Pharmacology and Experimental Therapeutics, 294, 88-95.
    • (2000) Journal of Pharmacology and Experimental Therapeutics , vol.294 , pp. 88-95
    • Obach, R.S.1
  • 28
    • 0018668570 scopus 로고
    • Effect of altered plasma protein binding on apparent volume of distribution
    • OIE, S. and TOZER, T. N., 1979, Effect of altered plasma protein binding on apparent volume of distribution. Journal of Pharmaceutical Sciences, 68, 1203-1205.
    • (1979) Journal of Pharmaceutical Sciences , vol.68 , pp. 1203-1205
    • Oie, S.1    Tozer, T.N.2
  • 29
    • 78651165715 scopus 로고
    • The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature
    • OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370-2378.
    • (1964) Journal of Biological Chemistry , vol.239 , pp. 2370-2378
    • Omura, T.1    Sato, R.2
  • 30
    • 0032546575 scopus 로고    scopus 로고
    • Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: Detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate
    • RACHA, J. K., RETTIE, A. E. and KUNZE, K. L., 1998, Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate. Biochemistry, 37, 7407-7419.
    • (1998) Biochemistry , vol.37 , pp. 7407-7419
    • Racha, J.K.1    Rettie, A.E.2    Kunze, K.L.3
  • 31
    • 0021162586 scopus 로고
    • Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals
    • SAWADA, Y., HANANO, M., SUGIYAMA, Y. and IGA, T., 1984, Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals. Journal of Pharmacokinetics Biopharmaceutical, 12, 241-261.
    • (1984) Journal of Pharmacokinetics Biopharmaceutical , vol.12 , pp. 241-261
    • Sawada, Y.1    Hanano, M.2    Sugiyama, Y.3    Iga, T.4
  • 33
    • 0034130633 scopus 로고    scopus 로고
    • Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors
    • SOUNESS, J. E., ALDOUS, D. and SARGENT, C., 2000, Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology, 47, 127-162.
    • (2000) Immunopharmacology , vol.47 , pp. 127-162
    • Souness, J.E.1    Aldous, D.2    Sargent, C.3
  • 34
    • 0036179579 scopus 로고    scopus 로고
    • (+)-N-3-benzylnirvanol and (-)-N-3-benzyl-phenoparbital: New potent and selective in vitro inhibitors of CYP2C19
    • SUZUKI, H., KNELLER, B., HAINING, R. L., TRAGER, W. F. and RETTIE, A. E., 2002, (+)-N-3-benzylnirvanol and (-)-N-3-benzyl-phenoparbital: new potent and selective in vitro inhibitors of CYP2C19. Drug Metabolism and Disposition, 30, 235-239.
    • (2002) Drug Metabolism and Disposition , vol.30 , pp. 235-239
    • Suzuki, H.1    Kneller, B.2    Haining, R.L.3    Trager, W.F.4    Rettie, A.E.5
  • 35
    • 0018728344 scopus 로고
    • Pseudoephedrine pharmacokinetics in the rat using a microanalysis technique
    • TILL, A. E. and BENET, L. Z., 1979, Pseudoephedrine pharmacokinetics in the rat using a microanalysis technique. Pharmacology, 18, 306-310.
    • (1979) Pharmacology , vol.18 , pp. 306-310
    • Till, A.E.1    Benet, L.Z.2
  • 36
    • 0037369493 scopus 로고    scopus 로고
    • Verification of the selectivity of (+)N-3-benzylnirvanol as a CYP2C19 inhibitor
    • WALSKY, R. L. and OBACH, R. S., 2003, Verification of the selectivity of (+)N-3-benzylnirvanol as a CYP2C19 inhibitor. Drug Metabolism and Disposition, 31, 343.
    • (2003) Drug Metabolism and Disposition , vol.31 , pp. 343
    • Walsky, R.L.1    Obach, R.S.2
  • 37
    • 0021720605 scopus 로고
    • Results of a phase II study of the antidepressant effect of rolipram
    • ZELLER, E., STIEF, H. J., PFLUG, B. and SASTRE-Y-HERNANDEZ, M., 1984, Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiatry, 17, 188-190.
    • (1984) Pharmacopsychiatry , vol.17 , pp. 188-190
    • Zeller, E.1    Stief, H.J.2    Pflug, B.3    Sastre-Y-Hernandez, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.